Advances in the research of microRNA associated drug resistance in ovarian cancer / 国际肿瘤学杂志

ABSTRACT

Evidence is accumulating that aberrant microRNA(miRNA)expression contributes to the development and metastasis of cancer. Emerging evidence demonstrates that miRNA plays an important role in drug resistance in ovarian cancer and that it may become a new therapeutic target. It is important to further elucidate the mechanisms of miRNA associated drug resistance in ovarian cancer.